454 related articles for article (PubMed ID: 11342772)
21. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
[TBL] [Abstract][Full Text] [Related]
22. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
Pan CC; Chen PC; Chou TY; Chiang H
Hum Pathol; 2003 Nov; 34(11):1155-62. PubMed ID: 14652817
[TBL] [Abstract][Full Text] [Related]
23. Expression of thrombomodulin, calretinin, cytokeratin 5/6, D2-40 and WT-1 in a series of primary carcinomas of the lung: an immunohistochemical study in comparison with epithelioid pleural mesothelioma.
Comin CE; Novelli L; Cavazza A; Rotellini M; Cianchi F; Messerini L
Tumori; 2014; 100(5):559-67. PubMed ID: 25343553
[TBL] [Abstract][Full Text] [Related]
24. TLE1 expression in malignant mesothelioma.
Matsuyama A; Hisaoka M; Iwasaki M; Iwashita M; Hisanaga S; Hashimoto H
Virchows Arch; 2010 Nov; 457(5):577-83. PubMed ID: 20857142
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis.
Carella R; Deleonardi G; D'Errico A; Salerno A; Egarter-Vigl E; Seebacher C; Donazzan G; Grigioni WF
Am J Surg Pathol; 2001 Jan; 25(1):43-50. PubMed ID: 11145250
[TBL] [Abstract][Full Text] [Related]
26. Primary intrathoracic synovial sarcoma: a clinicopathologic study of 40 t(X;18)-positive cases from the French Sarcoma Group and the Mesopath Group.
Bégueret H; Galateau-Salle F; Guillou L; Chetaille B; Brambilla E; Vignaud JM; Terrier P; Groussard O; Coindre JM
Am J Surg Pathol; 2005 Mar; 29(3):339-46. PubMed ID: 15725802
[TBL] [Abstract][Full Text] [Related]
27. Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young females.
Shanks JH; Harris M; Banerjee SS; Eyden BP; Joglekar VM; Nicol A; Hasleton PS; Nicholson AG
Am J Surg Pathol; 2000 Feb; 24(2):285-94. PubMed ID: 10680897
[TBL] [Abstract][Full Text] [Related]
28. Fine-needle aspiration biopsy of synovial sarcoma. A cytomorphologic analysis of primary, recurrent, and metastatic tumors.
Kilpatrick SE; Teot LA; Stanley MW; Ward WG; Savage PD; Geisinger KR
Am J Clin Pathol; 1996 Dec; 106(6):769-75. PubMed ID: 8980353
[TBL] [Abstract][Full Text] [Related]
29. The immunohistochemical profile of malignant mesotheliomas of the tunica vaginalis: a study of 20 cases.
Winstanley AM; Landon G; Berney D; Minhas S; Fisher C; Parkinson MC
Am J Surg Pathol; 2006 Jan; 30(1):1-6. PubMed ID: 16330935
[TBL] [Abstract][Full Text] [Related]
30. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
Ordóñez NG
Hum Pathol; 2005 Apr; 36(4):372-80. PubMed ID: 15891998
[TBL] [Abstract][Full Text] [Related]
31. Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: implications in tumor diagnosis.
Miettinen M; Fetsch JF
Hum Pathol; 2000 Sep; 31(9):1062-7. PubMed ID: 11014572
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesotheliomas and primary pulmonary adenocarcinomas.
Foster MR; Johnson JE; Olson SJ; Allred DC
Arch Pathol Lab Med; 2001 Oct; 125(10):1316-20. PubMed ID: 11570906
[TBL] [Abstract][Full Text] [Related]
33. Monophasic and biphasic synovial sarcoma. An immunohistochemical study.
Tsujimoto M; Ueda T; Nakashima H; Hamada H; Ishiguro S; Aozasa K
Acta Pathol Jpn; 1987 Apr; 37(4):597-604. PubMed ID: 2441569
[TBL] [Abstract][Full Text] [Related]
34. The correlation between morphology and the expression of TGF-β signaling pathway proteins and epithelial-mesenchymal transition-related proteins in synovial sarcomas.
Qi Y; Wang CC; He YL; Zou H; Liu CX; Pang LJ; Hu JM; Jiang JF; Zhang WJ; Li F
Int J Clin Exp Pathol; 2013; 6(12):2787-99. PubMed ID: 24294365
[TBL] [Abstract][Full Text] [Related]
35. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
Rekhi B; Vogel U
APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
[TBL] [Abstract][Full Text] [Related]
36. Epithelioid sarcoma: new insights based on an extended immunohistochemical analysis.
Laskin WB; Miettinen M
Arch Pathol Lab Med; 2003 Sep; 127(9):1161-8. PubMed ID: 12946229
[TBL] [Abstract][Full Text] [Related]
37. The value of antibodies 44-3A6, SM3, HBME-1, and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: a comparative study with other commonly used antibodies.
Ordóñez NG
Am J Surg Pathol; 1997 Dec; 21(12):1399-408. PubMed ID: 9414183
[TBL] [Abstract][Full Text] [Related]
38. Poorly differentiated synovial sarcoma: an analysis of clinical, pathologic, and molecular genetic features.
van de Rijn M; Barr FG; Xiong QB; Hedges M; Shipley J; Fisher C
Am J Surg Pathol; 1999 Jan; 23(1):106-12. PubMed ID: 9888710
[TBL] [Abstract][Full Text] [Related]
39. A comparative immunohistochemical study of malignant mesothelioma and renal cell carcinoma: the diagnostic utility of Leu-M1, Ber EP4, Tamm-Horsfall protein and thrombomodulin.
Attanoos RL; Goddard H; Thomas ND; Jasani B; Gibbs AR
Histopathology; 1995 Oct; 27(4):361-6. PubMed ID: 8847067
[TBL] [Abstract][Full Text] [Related]
40. Solitary fibrous tumors are immunophenotypically distinct from mesothelioma(s).
Morgan MB; Smoller BR
J Cutan Pathol; 2000 Oct; 27(9):451-4. PubMed ID: 11028815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
